Mon, June 27, 2011
Sat, June 25, 2011
Fri, June 24, 2011
Thu, June 23, 2011
Wed, June 22, 2011
Tue, June 21, 2011
Mon, June 20, 2011
Sun, June 19, 2011
Fri, June 17, 2011
Thu, June 16, 2011
Wed, June 15, 2011
Tue, June 14, 2011
[ Tue, Jun 14th 2011 ]: Market Wire
Bond Labs Reports May Results
Mon, June 13, 2011
Fri, June 10, 2011
Thu, June 9, 2011
Wed, June 8, 2011
Tue, June 7, 2011
Mon, June 6, 2011
Sat, June 4, 2011
Fri, June 3, 2011
Thu, June 2, 2011
Wed, June 1, 2011
Tue, May 31, 2011
Mon, May 30, 2011
Fri, May 27, 2011
Thu, May 26, 2011

Alkermes' Corporate Presentation to be Webcast at the NASDAQ OMX 26th Investor Program


  Copy link into your clipboard //health-fitness.news-articles.net/content/2011/ .. ast-at-the-nasdaq-omx-26th-investor-program.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

WALTHAM, Mass.--([ BUSINESS WIRE ])--[ Alkermes, Inc. ] (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the NASDAQ OMX 26th Investor Programon Tuesday, June 21, 2011, at 8:30 a.m. BST (3:30 a.m. ET) from the May Fair Hotel in London. The presentation may be accessed under the investor relations tab at [ www.alkermes.com ] and will be archived for 14 days.

Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL for alcohol and opioid dependence and manufactures RISPERDAL CONSTAfor schizophrenia and bipolar I disorder. Alkermes' robust pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Waltham, Massachusetts, Alkermes has a research facility in Massachusetts and a commercial manufacturing facility in Ohio.


Publication Contributing Sources